Gerald Bodey Interview, 2003
Files
Download Interview Transcript (385 KB)
Loading...
Description
Major Topics Covered:
- Collaborating with Emil J Freireich on the laminar air flow rooms
- Influences to study oncology
Interview Chapters
Chapter 02: Career at MD Anderson – From Developmental Therapeutics to Medical Specialties
Chapter 03: Research into Leukemia: Life Islands and Laminar Air Flow Units
Chapter 04: Formative Experiences Random Controlled Trials at the NCI
Chapter 05: “The World’s Authority on Infectious Diseases”
Chapter 07: Evolution of Medical Practices in Neoplasms and Drug Therapy
Chapter 08: Professional Activities and Working with NASA and NCI
Publication Date
3-3-2003
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Topics Covered
University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center, University of Texas System. M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute at Houston, University of Texas M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute
Subject Headings
Bodey, Gerald P.; Frei, Emil, 1924-; Freireich, Emil J., 1927-; Krakoff, Irwin H.; National Cancer Institute (U.S.); University of Texas M.D. Anderson Cancer Center -- history; University of Texas M.D. Anderson Cancer Center. Developmental Therapeutics; Research; Antineoplastic Combined Chemotherapy Protocols; Leukemia; Chemotherapy, Adjuvant; Clinical Trials as Topic; Randomized Controlled Trials as Topic; Leukemia -- drug therapy; Laboratories, Hospital; Hospitals, Special; Hospital Departments; Patient Isolators; Neoplasms -- prevention and control; Pseudomonas Infections; Carbenicillin; Communicable Diseases; Mycoses; Houston (Tex.); Oral History; Interviews;
Disciplines
History of Science, Technology, and Medicine | Oncology | Oral History
Recommended Citation
Bodey, Gerald P. MD and Brunet, Lesley W., "Gerald Bodey Interview, 2003" (2003). Interview Sessions. 231.
https://openworks.mdanderson.org/mchv_interviewsessions/231
Conditions Governing Access
Redacted
About the Interview
Biographical Note:
Dr. Gerald P. Bodey was born in Hazelton, Pennsylvania on May 22, 1934. He attended Lafayette College where he graduated magna cum laude in 1956. After completing his medical education at Johns Hopkins University, Dr. Bodey spent three years at the National Cancer Institute. An interest in acute leukemia led to his joining the faculty of the University of Texas M.D. Anderson Cancer Center in 1966 where he collaborated with Dr. Emil Freireich in establishing adult acute leukemia service. In 1975, he became a professor of medicine and served as chief of the Cancer Chemotherapy Branch in the Department of Developmental Therapeutics. Later, he founded the Section of Infectious Diseases and was appointed the first director of the Office of Protocol Research. In 1987, Dr. Bodey was named chairman of the Department of Medical Specialties, a post he held until he retired in 1995.
Dr. Bodey is an internationally recognized figure in leukemia research, having lectured professionally in numerous countries. In addition, he has authored or co-authored more than 1,000 publications and has been recognized twice by the Institute for Scientific Information as one of the 300 most cited authors in scientific literature. In 2004, Dr. Bodey was recognized by the University of Texas M.D. Anderson Cancer Center with a lectureship in his honor for his many years of service in fighting infections in neutropenic patients. Dr. Bodey currently resides in The Woodlands, TX where he retains the title Emeritus Professor in the Department of Medicine in the Section of Infectious Diseases at the University of Texas M.D. Anderson Cancer Center.
Abstract:
The interview with Dr. Gerald P. Bodey begins with the evolution of his medical career. His various positions held at M.D. Anderson are also recounted. The interview continues with a description of several of his major contributions to medicine, including his work with laminar airflow units and netropenic patients. His collaborative work with Dr. Emil Freireich concerning leukemia patients and drug therapy is also highlighted. Dr. Bodey’s professional activities and international involvement are discussed as well. The interview concludes with a discussion regarding the influences and career decisions which led to his decision to study oncology.